Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

November 15, New Zealand Joins Phase 2B Pet Dog Trial

211115_NZ Trial Centres

Categories: Financial Reports 2017, News and Announcements 2021By Richard Mollard November 15, 2021

Related posts

December 15, Epichem Awarded DNDi Extension
December 15, 2021

December 13, Shareholder Update and Strategy
December 13, 2021

December 1, Demonstration Batch Small MPL Tablets Completed
December 1, 2021

December 1, Top 20 Shareholders
December 1, 2021

November 17, FightMND and COVID-19 Trials on Track
November 17, 2021

November 1, Top 20 Shareholders
November 1, 2021

Recent Articles

May 11, PharmAust Expands Canine Trial to the US
May 11, 2022
May 1, Top 20 Shareholders
May 1, 2022
April 29, Appendix 4C and Quarterly Update
April 29, 2022
April 19, PharmAust Receives $708k R&D Tax Rebate
April 19, 2022

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

Retweet on Twitter PharmAust Retweeted

F I G H T M N D @FightMND·

From 9 am - 4pm, this Saturday 28 May, our friends at @Bunnings are hosting a sausage sizzle at six selected stores across the country this Saturday 28 May.

Local Aussie celebrity icons and FightMND volunteers will man the BBQs and serve snags to help raise funds for FightMND.

Reply on Twitter 1529643503952740357 Retweet on Twitter 15296435039527403572 Like on Twitter 15296435039527403573 Twitter 1529643503952740357

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions